We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > REGN-EB3

News List

Regeneron's BLA for Ebola Cocktail Gets Priority Review contractpharma
April 17, 2020
VelociSuite technologies facilitate rapid generation of optimized antibodies allowing for cell line production and large-scale bioreactor manufacturing.
Ebola clinical trial stopped early due to positive results europeanpharmaceuticalreview
August 14, 2019
An Ebola clinical trial has been stopped early as Regeneron’s REGN-EB3 therapy shows superiority to ZMapp in preventing Ebola deaths.
New Ebola Drugs Highly Effective, Might Shorten Outbreak in Africa drugs
August 13, 2019
Two experimental Ebola treatments have worked so well in the Democratic Republic of Congo outbreak that they will be offered to all patients, scientists say.